Merck KGaA and Remepy join forces to develop combo drug-digital therapies
Summary
Merck KGaA and Remepy will work in tandem to develop drug-digital therapy combinations for a rare cancer indication.
Description
Merck KGaA and Remepy will work in tandem to develop drug-digital therapy combinations for a rare cancer indication.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source